Flubendazole demonstrates valid antitumor effects by inhibiting STAT3 and activating autophagy

to related objects

Location: Deutsche Nationalbibliothek Frankfurt am Main

ISSN: 1756-9966

Extent: Online-Ressource

Language: Englisch

Notes: online resource.

Bibliographic citation: Flubendazole demonstrates valid antitumor effects by inhibiting STAT3 and activating autophagy ; volume:38 ; number:1 ; day:8 ; month:7 ; year:2019 ; pages:1-13 ; date:12.2019
Journal of experimental & clinical cancer research ; 38, Heft 1 (8.7.2019), 1-13, 12.2019

Creator: Lin, Shichong
Yang, Lehe
Yao, Yulei
Xu, Lingyuan
Xiang, Youqun
Zhao, Haiyang
Wang, Liangxing
Zuo, Zhigui
Huang, Xiaoying
Zhao, Chengguang

Contributor: SpringerLink (Online service)

DOI: 10.1186/s13046-019-1303-z

URN: urn:nbn:de:101:1-2019110520492286525621

Rights: Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.

Last update: 15.08.2025, 7:20 AM CEST

Data provider

This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.

Show original at data provider

Associated

Lin, Shichong
Yang, Lehe
Yao, Yulei
Xu, Lingyuan
Xiang, Youqun
Zhao, Haiyang
Wang, Liangxing
Zuo, Zhigui
Huang, Xiaoying
Zhao, Chengguang
SpringerLink (Online service)

Other Objects (12)

ARF6 promotes hepatocellular carcinoma proliferation through activating STAT3 signaling

Recombinant Newcastle disease virus expressing P53 demonstrates promising antitumor efficiency in hepatoma model

Stat3-mediated Atg7 expression regulates anti-tumor immunity in mouse melanoma

CAA-derived IL-6 induced M2 macrophage polarization by activating STAT3

METTL3 promotes colorectal cancer progression through activating JAK1/STAT3 signaling pathway

E7080 (Lenvatinib), a Multi-Targeted Tyrosine Kinase Inhibitor, Demonstrates Antitumor Activities Against Colorectal Cancer Xenografts

Targeted transcriptional downregulation of MYC using epigenomic controllers demonstrates antitumor activity in hepatocellular carcinoma models

Selinexor (KPT-330) demonstrates anti-tumor efficacy in preclinical models of triple-negative breast cancer

IL-17A induces osteoblast differentiation by activating JAK2/STAT3 in ankylosing spondylitis

From Valid Measurements to Valid Mini-Apps

Zinc protoporphyrin IX, a heme oxygenase-1 inhibitor, demonstrates potent antitumor effects but is unable to potentiate antitumor effects of chemotherapeutics in mice

Gentulizumab, a novel anti-CD47 antibody with potent antitumor activity and demonstrates a favorable safety profile

ARF6 promotes hepatocellular carcinoma proliferation through activating STAT3 signaling

Recombinant Newcastle disease virus expressing P53 demonstrates promising antitumor efficiency in hepatoma model

Stat3-mediated Atg7 expression regulates anti-tumor immunity in mouse melanoma

CAA-derived IL-6 induced M2 macrophage polarization by activating STAT3

METTL3 promotes colorectal cancer progression through activating JAK1/STAT3 signaling pathway

E7080 (Lenvatinib), a Multi-Targeted Tyrosine Kinase Inhibitor, Demonstrates Antitumor Activities Against Colorectal Cancer Xenografts

Targeted transcriptional downregulation of MYC using epigenomic controllers demonstrates antitumor activity in hepatocellular carcinoma models

Selinexor (KPT-330) demonstrates anti-tumor efficacy in preclinical models of triple-negative breast cancer

IL-17A induces osteoblast differentiation by activating JAK2/STAT3 in ankylosing spondylitis

From Valid Measurements to Valid Mini-Apps

Zinc protoporphyrin IX, a heme oxygenase-1 inhibitor, demonstrates potent antitumor effects but is unable to potentiate antitumor effects of chemotherapeutics in mice

Gentulizumab, a novel anti-CD47 antibody with potent antitumor activity and demonstrates a favorable safety profile

ARF6 promotes hepatocellular carcinoma proliferation through activating STAT3 signaling

Recombinant Newcastle disease virus expressing P53 demonstrates promising antitumor efficiency in hepatoma model

Stat3-mediated Atg7 expression regulates anti-tumor immunity in mouse melanoma

CAA-derived IL-6 induced M2 macrophage polarization by activating STAT3

METTL3 promotes colorectal cancer progression through activating JAK1/STAT3 signaling pathway

E7080 (Lenvatinib), a Multi-Targeted Tyrosine Kinase Inhibitor, Demonstrates Antitumor Activities Against Colorectal Cancer Xenografts

Targeted transcriptional downregulation of MYC using epigenomic controllers demonstrates antitumor activity in hepatocellular carcinoma models

Selinexor (KPT-330) demonstrates anti-tumor efficacy in preclinical models of triple-negative breast cancer

IL-17A induces osteoblast differentiation by activating JAK2/STAT3 in ankylosing spondylitis

From Valid Measurements to Valid Mini-Apps

Zinc protoporphyrin IX, a heme oxygenase-1 inhibitor, demonstrates potent antitumor effects but is unable to potentiate antitumor effects of chemotherapeutics in mice

Gentulizumab, a novel anti-CD47 antibody with potent antitumor activity and demonstrates a favorable safety profile

Cultural heritage institutions wishing to register will find more information here.

Fields marked * need to be filled in.

Username*

Please enter your username

Email*

Please enter your email address

Please do not fill this field

First name

Last name

Password*

Please enter your password

Confirm password*

Please enter the same password

I have read the terms of use and the privacy policy for the collection of personal data and accept them. *

This field is required.

I would like to subscribe to the newsletter of the Deutsche Digitale Bibliothek. See newsletter subscription info.

Account created

Your "My DDB" account has been successfully created. Before you can log in to your account, you must click the confirmation link in the message we just sent to the email address you provided.

Flubendazole demonstrates valid antitumor effects by inhibiting STAT3 and activating autophagy

Object Details

References and Relationships

Contributors, Places and Time

Further information

Data provider

Associated

Other Objects (12)

ARF6 promotes hepatocellular carcinoma proliferation through activating STAT3 signaling

Recombinant Newcastle disease virus expressing P53 demonstrates promising antitumor efficiency in hepatoma model

Stat3-mediated Atg7 expression regulates anti-tumor immunity in mouse melanoma

CAA-derived IL-6 induced M2 macrophage polarization by activating STAT3

METTL3 promotes colorectal cancer progression through activating JAK1/STAT3 signaling pathway

E7080 (Lenvatinib), a Multi-Targeted Tyrosine Kinase Inhibitor, Demonstrates Antitumor Activities Against Colorectal Cancer Xenografts

Targeted transcriptional downregulation of MYC using epigenomic controllers demonstrates antitumor activity in hepatocellular carcinoma models

Selinexor (KPT-330) demonstrates anti-tumor efficacy in preclinical models of triple-negative breast cancer

IL-17A induces osteoblast differentiation by activating JAK2/STAT3 in ankylosing spondylitis

From Valid Measurements to Valid Mini-Apps

Zinc protoporphyrin IX, a heme oxygenase-1 inhibitor, demonstrates potent antitumor effects but is unable to potentiate antitumor effects of chemotherapeutics in mice

Gentulizumab, a novel anti-CD47 antibody with potent antitumor activity and demonstrates a favorable safety profile

ARF6 promotes hepatocellular carcinoma proliferation through activating STAT3 signaling

Recombinant Newcastle disease virus expressing P53 demonstrates promising antitumor efficiency in hepatoma model

Stat3-mediated Atg7 expression regulates anti-tumor immunity in mouse melanoma

CAA-derived IL-6 induced M2 macrophage polarization by activating STAT3

METTL3 promotes colorectal cancer progression through activating JAK1/STAT3 signaling pathway

E7080 (Lenvatinib), a Multi-Targeted Tyrosine Kinase Inhibitor, Demonstrates Antitumor Activities Against Colorectal Cancer Xenografts

Targeted transcriptional downregulation of MYC using epigenomic controllers demonstrates antitumor activity in hepatocellular carcinoma models

Selinexor (KPT-330) demonstrates anti-tumor efficacy in preclinical models of triple-negative breast cancer

IL-17A induces osteoblast differentiation by activating JAK2/STAT3 in ankylosing spondylitis

From Valid Measurements to Valid Mini-Apps

Zinc protoporphyrin IX, a heme oxygenase-1 inhibitor, demonstrates potent antitumor effects but is unable to potentiate antitumor effects of chemotherapeutics in mice

Gentulizumab, a novel anti-CD47 antibody with potent antitumor activity and demonstrates a favorable safety profile

ARF6 promotes hepatocellular carcinoma proliferation through activating STAT3 signaling

Recombinant Newcastle disease virus expressing P53 demonstrates promising antitumor efficiency in hepatoma model

Stat3-mediated Atg7 expression regulates anti-tumor immunity in mouse melanoma

CAA-derived IL-6 induced M2 macrophage polarization by activating STAT3

METTL3 promotes colorectal cancer progression through activating JAK1/STAT3 signaling pathway

E7080 (Lenvatinib), a Multi-Targeted Tyrosine Kinase Inhibitor, Demonstrates Antitumor Activities Against Colorectal Cancer Xenografts

Targeted transcriptional downregulation of MYC using epigenomic controllers demonstrates antitumor activity in hepatocellular carcinoma models

Selinexor (KPT-330) demonstrates anti-tumor efficacy in preclinical models of triple-negative breast cancer

IL-17A induces osteoblast differentiation by activating JAK2/STAT3 in ankylosing spondylitis

From Valid Measurements to Valid Mini-Apps

Zinc protoporphyrin IX, a heme oxygenase-1 inhibitor, demonstrates potent antitumor effects but is unable to potentiate antitumor effects of chemotherapeutics in mice

Gentulizumab, a novel anti-CD47 antibody with potent antitumor activity and demonstrates a favorable safety profile

Related objects

Reset password